Publications by authors named "Giorgio Sciarra"
Clin Exp Rheumatol
March 2023
Article Synopsis
- The study investigates the effects of switching from the ADA bio-originator to the SB5 biosimilar, along with switching between different biosimilars of the same drug for patients with inflammatory chronic arthritis.
- Results showed a significant drop in the percentage of patients in remission or low disease activity after switching from the ADA bio-originator to SB5, indicating potential risks associated with this non-medical switch.
- Conversely, switching between two different biosimilars (ABP501 to SB5) did not show significant changes in disease activity levels or patient remission rates over a 4-month period.
